Insulin-like Growth Factor Binding Protein-4 (N-Terminal)

• Description:

  insulin-like growth factor binding protein-4 (N-Terminal)_x000D_ Catalog number: B2010570_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 0.1 mg_x000D_ Molecular Weight or Concentration: 15 kDa_x000D_ Supplied as: Lyophilized_x000D_ Applications: molecular tool in the study of IGFBP family of proteins_x000D_ Storage: -20C_x000D_ Keywords: NT-IGFBP-4_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Austin K, Tsang D, Chalmers JA, Maalouf MF, Brubaker PL. Insulin-like growth_x000D_ factor-binding protein-4 inhibits epithelial growth and proliferation in the_x000D_ rodent intestine. Am J Physiol Gastrointest Liver Physiol. 2018 Aug_x000D_ 1;315(2):G206-G219._x000D_ _x000D_ 2: Durai R, Davies M, Yang W, Yang SY, Seifalian A, Goldspink G, Winslet M._x000D_ Biology of insulin-like growth factor binding protein-4 and its role in cancer_x000D_ (review). Int J Oncol. 2006 Jun;28(6):1317-25._x000D_ _x000D_ 3: Li H, Yu S, Hao F, Sun X, Zhao J, Xu Q, Duan D. Insulin-like growth factor_x000D_ binding protein 4 inhibits proliferation of bone marrow mesenchymal stem cells_x000D_ and enhances growth of neurospheres derived from the stem cells. Cell Biochem_x000D_ Funct. 2018 Aug;36(6):331-341._x000D_ _x000D_ 4: You Q, Wu Y, Yao N, Shen G, Zhang Y, Xu L, Li G, Ju C. Interaction of AIM_x000D_ with insulin-like growth factor-binding protein-4. Int J Mol Med. 2015_x000D_ Sep;36(3):833-8._x000D_ _x000D_ 5: Mohan S, Baylink DJ. Serum insulin-like growth factor binding protein_x000D_ (IGFBP)-4 and IGFBP-5 levels in aging and age-associated diseases. Endocrine._x000D_ 1997 Aug;7(1):87-91._x000D_ _x000D_ 6: Wu T, Xie C, Han J, Ye Y, Singh S, Zhou J, Li Y, Ding H, Li QZ, Zhou X,_x000D_ Putterman C, Saxena R, Mohan C. Insulin-Like Growth Factor Binding Protein-4 as_x000D_ a Marker of Chronic Lupus Nephritis. PLoS One. 2016 Mar 28;11(3):e0151491._x000D_ _x000D_ 7: Sato H, Sakaeda M, Ishii J, Kashiwagi K, Shimoyamada H, Okudela K, Tajiri M,_x000D_ Ohmori T, Ogura T, Woo T, Masuda M, Hirata K, Kitamura H, Yazawa T. Insulin-like_x000D_ growth factor binding protein-4 gene silencing in lung adenocarcinomas. Pathol_x000D_ Int. 2011 Jan;61(1):19-27._x000D_ _x000D_ 8: Bach LA. Insulin-Like Growth Factor Binding Proteins--an Update. Pediatr_x000D_ Endocrinol Rev. 2015 Dec;13(2):521-30._x000D_ _x000D_ 9: Contois LW, Nugent DP, Caron JM, Cretu A, Tweedie E, Akalu A, Liebes L,_x000D_ Friesel R, Rosen C, Vary C, Brooks PC. Insulin-like growth factor binding_x000D_ protein-4 differentially inhibits growth factor-induced angiogenesis. J Biol_x000D_ Chem. 2012 Jan 13;287(3):1779-89._x000D_ 10: Hjortebjerg R, Lindberg S, Pedersen S, Mogelvang R, Jensen JS, Oxvig C,_x000D_ Frystyk J, Bjerre M. Insulin-Like Growth Factor Binding Protein 4 Fragments_x000D_ Provide Incremental Prognostic Information on Cardiovascular Events in Patients_x000D_ With ST-Segment Elevation Myocardial Infarction. J Am Heart Assoc. 2017 Mar_x000D_ 17;6(3):e005358. _x000D_ _x000D_ Products Related to insulin-like growth factor binding protein-4 (N-Terminal): Proteins

• Short Description:

  Catalog Number: B2010570 (0.1 mg)_x000D_ Insulin-like Growth Factor Binding Protein-4 (N-Terminal) is a highly pure N-terminal fragment of insulin-like growth factor binding protein-4 (IGFBP-4). This product has been used as molecular tool in the study of IGFBP family of proteins. It has also been used in a wide array of other biochemical and immunological applications. Custom bulk amounts of this product are available upon request._x000D_ _x000D_

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height :

  0.5